Medtronic plc.

Open: 77.28 Close: 76.54 Change: -0.74

The stock market through the eyes of an AI: Medtronic plc. Company Inc Stock.

The game is changing. There is a new strategy to evaluate Medtronic plc. fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, Medtronics, Carlyle, plc, medical, company, business, …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

Carlyle Group Inc. (CG.O) has entered into exclusive negotiations to acquire a majority stake in two medical device businesses of Medtronic Plc (MDTN) Carlyle seeks roughly $2.5 billion debt for medtronic units bid. Carlyle would retain a 35% stake in the new company.

Today's News

Medtronic PLC stock falls t Tuesday, underperforms market - marketwatch.com. S&P 500 Index SPX, -1.37% DJIA and Dow Jones Industrial Average DJIA fall. Private equity firm Carlyle Group Inc. (CG.O) has entered into exclusive negotiations to acquire a majority stake in two medical device businesses of Medtronic Plc (MDTN) at a valuation of more than $7 billion. Carlyle would retain a 35% stake in the new company, the sources added. Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The company is seeking to streamline its portfolio and focus on its higher-growth assets. Dr. Washington is the Senior Vice President, Chief Technology and Innovation Officer of Medtronic plc (NYSE: MDT) He was appointed to this position in June 2023. Carlyle Seeks Roughly $2.5 billion debt for Medtronic Units Bid. Carlyle Group Inc. A Look At The Intrinsic Value Of Medtronics plc (NYSE:MDT) Using the 2 Stage Free Cash Flow to Equity, Medtron fair value estimate is US$86.90 Current share price is 76.54. Carlyle Seeks Roughly $2.5 Billion Debt for Medtronic Units Bid. Carlyle seeks roughly $2.5 billion debt for medtronic units bid. Medtronics manufactures more than half of all pacemakers implanted worldwide. Medtronic has 104,950 employees and generates $31.7B in revenue. Company average salary at $83,546 in Los Angeles, NY, NY 35 $78,431. Highest paying Medtronics competitors include Intuitive Surgical, Edwards Lifesciences, Genentech, Bio-Rad Laboratories, and Hologic. Robinhood gives you the tools you need to put your money in motion. You can buy or sell Medtronic and other ETFs, options, and stocks. Medtronic is expanding its global foothold within the Cardiovascular business (contributing more than 37% to total revenues in fiscal 2023). Within Cardiovascular, cardiac rhythm management, one of Medtronics largest businesses, continued to build on the companys category leadership. Within MedSurg, the company is gaining from the positive sales momentum. Medtronic and TMCF have partnered since 2020 to develop an annual internship program across the U.S., as well as a scholarship program sponsored by the Medtronics Foundation. Medtronic PLC shares MDT, -0.05% were down 1.3% premarket on Thursday after advisors to the U.S. voted against recommending the approval of Medtronics blood pressure treatment device. Medtronic plc (MDT) - 10-K - Annual Report SEC Filings Thu, Jun. 11 Medtronics plc. (MD) - 8-K- - Current. report. Medtronic plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services.

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

Are looking for the most relevant information about Medtronic plc.? Investor spend a lot of time searching for information to make investment decisions in Medtronic plc.. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, Medtronics, Carlyle, plc, medical, company, business, and the most common words in the summary are: medtronic, stock, job, plc, mdt, market, price, . One of the sentences in the summary was: Carlyle would retain a 35% stake in the new company.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #stock #job #plc #mdt #market #price.